Nasdaq · Common stock
Parabilis Medicines (PBLS)
$25.03 +$0.59 (+2.41%)
- Day’s range
- $23.06–$25.59
- Volume
- 1.4M
PBLS price history
PBLS closed at $25.03 on Oct. 26, 2026. Over the past year, its daily close ranged from $22.75 on Oct. 16, 2026 to $41.73 on Sept. 18, 2026.
Data table: PBLS daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $25.03 |
| Oct. 23, 2026 | $24.44 |
| Oct. 22, 2026 | $26.92 |
| Oct. 21, 2026 | $27.85 |
| Oct. 20, 2026 | $27.08 |
| Oct. 19, 2026 | $25.35 |
| Oct. 16, 2026 | $22.75 |
| Oct. 15, 2026 | $25.18 |
| Oct. 14, 2026 | $25.89 |
| Oct. 13, 2026 | $26.85 |
| Oct. 12, 2026 | $28.95 |
| Oct. 9, 2026 | $27.48 |
| Oct. 8, 2026 | $28.09 |
| Oct. 7, 2026 | $28.82 |
| Oct. 6, 2026 | $28.86 |
| Oct. 5, 2026 | $29.53 |
| Oct. 2, 2026 | $30.28 |
| Oct. 1, 2026 | $30.44 |
| Sept. 30, 2026 | $32.29 |
| Sept. 29, 2026 | $31.91 |
| Sept. 28, 2026 | $32.57 |
| Sept. 25, 2026 | $31.20 |
| Sept. 24, 2026 | $32.47 |
| Sept. 23, 2026 | $33.31 |
| Sept. 22, 2026 | $38.17 |
| Sept. 21, 2026 | $36.93 |
| Sept. 18, 2026 | $41.73 |
| Sept. 17, 2026 | $40.88 |
| Sept. 16, 2026 | $36.88 |
| Sept. 15, 2026 | $35.72 |
| Sept. 14, 2026 | $36.16 |
| Sept. 11, 2026 | $36.88 |
| Sept. 10, 2026 | $36.32 |
| Sept. 9, 2026 | $38.76 |
| Sept. 8, 2026 | $39.77 |
| Sept. 4, 2026 | $40.42 |
| Sept. 3, 2026 | $40.75 |
| Sept. 2, 2026 | $40.11 |
| Sept. 1, 2026 | $39.47 |
| Aug. 31, 2026 | $39.01 |
| Aug. 28, 2026 | $39.11 |
| Aug. 27, 2026 | $39.29 |
| Aug. 26, 2026 | $39.26 |
| Aug. 25, 2026 | $39.23 |
| Aug. 24, 2026 | $38.43 |
| Aug. 21, 2026 | $39.36 |
| Aug. 20, 2026 | $39.58 |
| Aug. 19, 2026 | $41.32 |
| Aug. 18, 2026 | $39.35 |
| Aug. 17, 2026 | $37.22 |
| Aug. 14, 2026 | $37.07 |
| Aug. 13, 2026 | $35.67 |
| Aug. 12, 2026 | $37.41 |
| Aug. 11, 2026 | $36.47 |
| Aug. 10, 2026 | $35.73 |
| Aug. 7, 2026 | $34.98 |
| Aug. 6, 2026 | $35.58 |
| Aug. 5, 2026 | $34.90 |
| Aug. 4, 2026 | $35.90 |
| Aug. 3, 2026 | $33.96 |
| July 31, 2026 | $33.98 |
| July 30, 2026 | $32.28 |
| July 29, 2026 | $31.78 |
| July 28, 2026 | $31.96 |
| July 27, 2026 | $31.82 |
| July 24, 2026 | $31.28 |
| July 23, 2026 | $32.81 |
| July 22, 2026 | $30.81 |
| July 21, 2026 | $30.04 |
| July 20, 2026 | $27.31 |
| July 17, 2026 | $29.55 |
| July 16, 2026 | $29.06 |
| July 15, 2026 | $29.91 |
| July 14, 2026 | $31.15 |
| July 13, 2026 | $29.63 |
| July 10, 2026 | $30.57 |
| July 9, 2026 | $30.36 |
| July 8, 2026 | $30.83 |
| July 7, 2026 | $30.35 |
| July 6, 2026 | $29.20 |
| July 2, 2026 | $29.58 |
| July 1, 2026 | $27.76 |
| June 30, 2026 | $27.37 |
| June 29, 2026 | $29.19 |
| June 26, 2026 | $28.80 |
| June 25, 2026 | $26.36 |
| June 24, 2026 | $27.32 |
| June 23, 2026 | $27.51 |
| June 22, 2026 | $27.54 |
| June 18, 2026 | $25.85 |
| June 17, 2026 | $26.03 |
| June 16, 2026 | $26.59 |
| June 15, 2026 | $25.01 |
| June 12, 2026 | $27.26 |
| June 11, 2026 | $30.31 |
| June 10, 2026 | $31.60 |
Key figures
- Average daily volume
- 851,880Past 3 months
- Market value
- $3.09B
- Dividend yield
- —
Price change
- 1 month
- −19.78%
- 3 months
- −19.98%
What Wall Street says about PBLS
In the past 90 days, Wall Street firms published 1 rating or price-target action on PBLS: 1 new rating.
| Action | Rating | |||
|---|---|---|---|---|
| HC Wainwright & Co. | Initiates coverage | Buy | $40 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Parabilis Medicines, Inc. Common Stock
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
- Headquarters
- Cambridge, Mass.
- Listed
- June 10, 2026
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about PBLS is on the site yet.